As of 2025-03-17, the EV/EBITDA ratio of Vaxart Inc (VXRT) is -1.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VXRT's latest enterprise value is 105.47 mil USD. VXRT's TTM EBITDA according to its financial statements is -62.75 mil USD. Dividing these 2 quantities gives us the above VXRT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 13.3x | 12.2x |
| Forward P/E multiples | 17.3x - 34.9x | 21.6x |
| Fair Price | (4.69) - (3.59) | (4.59) |
| Upside | -970.2% - -765.6% | -950.8% |
| Date | EV/EBITDA |
| 2025-03-14 | -1.68 |
| 2025-03-13 | -1.60 |
| 2025-03-12 | -1.72 |
| 2025-03-11 | -1.40 |
| 2025-03-10 | -1.39 |
| 2025-03-07 | -1.43 |
| 2025-03-06 | -1.44 |
| 2025-03-05 | -1.43 |
| 2025-03-04 | -1.43 |
| 2025-03-03 | -1.44 |
| 2025-02-28 | -1.57 |
| 2025-02-27 | -1.51 |
| 2025-02-26 | -1.62 |
| 2025-02-25 | -1.52 |
| 2025-02-24 | -1.55 |
| 2025-02-21 | -2.31 |
| 2025-02-20 | -2.28 |
| 2025-02-19 | -2.36 |
| 2025-02-18 | -2.37 |
| 2025-02-14 | -2.43 |
| 2025-02-13 | -2.46 |
| 2025-02-12 | -2.35 |
| 2025-02-11 | -2.32 |
| 2025-02-10 | -2.23 |
| 2025-02-07 | -2.30 |
| 2025-02-06 | -2.40 |
| 2025-02-05 | -2.50 |
| 2025-02-04 | -2.32 |
| 2025-02-03 | -2.27 |
| 2025-01-31 | -2.19 |
| 2025-01-30 | -2.32 |
| 2025-01-29 | -2.35 |
| 2025-01-28 | -2.45 |
| 2025-01-27 | -2.37 |
| 2025-01-24 | -2.57 |
| 2025-01-23 | -2.52 |
| 2025-01-22 | -2.69 |
| 2025-01-21 | -2.50 |
| 2025-01-17 | -2.41 |
| 2025-01-16 | -2.41 |
| 2025-01-15 | -2.42 |
| 2025-01-14 | -2.38 |
| 2025-01-13 | -2.34 |
| 2025-01-10 | -2.59 |
| 2025-01-08 | -2.66 |
| 2025-01-07 | -2.90 |
| 2025-01-06 | -3.14 |
| 2025-01-03 | -2.76 |
| 2025-01-02 | -2.33 |
| 2024-12-31 | -2.13 |